Health Canada has approved Diagnos' computer-assisted retinal analysis (CARA) application, CARA-CCE, under a class II medical device licence. The product, which enhances retinal images and automatically highlights areas of possible pathology, is designed to help screen for diabetic retinopathy. ...
Please Login to read the full article.
